The Investor Relations website contains information about Assembly Biosciences, Inc. business for stockholders, potential investors, and financial analysts.
http://investor.assemblybio.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
1.2 seconds
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
8
SITE IP
206.200.251.19
LOAD TIME
1.219 sec
SCORE
6.2
Investor Relations - Assembly Biosciences, Inc. | investor.assemblybio.com Reviews
https://investor.assemblybio.com
The Investor Relations website contains information about Assembly Biosciences, Inc. business for stockholders, potential investors, and financial analysts.
investor.assemblybio.com
Annual Reports and Proxies - Assembly Biosciences, Inc.
http://investor.assemblybio.com/annuals-proxies.cfm
Annual Reports and Proxies. File is in Briefcase. File is in Briefcase. Apr 22, 2016. File is in Briefcase. Apr 13, 2015. File is in Briefcase. Jun 9, 2014. File is in Briefcase. Add file to Briefcase. Annual Reports and Proxies. 169; 2016 Assembly Biosciences, Inc.
Quarterly Results - Assembly Biosciences, Inc.
http://investor.assemblybio.com/results.cfm
Add file to Briefcase. Annual Reports and Proxies. 169; 2016 Assembly Biosciences, Inc.
Analyst Coverage - Assembly Biosciences, Inc.
http://investor.assemblybio.com/analysts.cfm
Assembly Biosciences, Inc. is covered by the following analysts. Please note that any opinions, estimates or forecasts regarding Assembly Biosciences, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Assembly Biosciences, Inc. or its management. Assembly Biosciences, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
Investor Relations - Assembly Biosciences, Inc.
http://investor.assemblybio.com/index.cfm
Assembly Biosciences, Inc. (Nasdaq: ASMB) is a public biotechnology company advancing a new class of oral biologic drugs for addressing the gut microbiome and novel approaches to discovering drugs for the treatment of hepatitis B virus (HBV) infection. 4:00 PM ET on Aug 26, 2016. Delayed at least 20 minutes. Assembly Biosciences to Present at the Jefferies 2016 Global Healthcare Conference. See all press releases. See all press releases. June 07, 2016 at 11:00 AM ET. April 15, 2016 at 8:00 AM CET.
Assembly Biosciences Discusses Mechanism of Action of Its HBV Antiviral Program at 2nd ANRS HBV Cure Workshop (NASDAQ:ASMB)
http://investor.assemblybio.com/releasedetail.cfm?ReleaseID=913815
May 19, 2015. File is in Briefcase. Assembly Biosciences Discusses Mechanism of Action of Its HBV Antiviral Program at 2nd ANRS HBV Cure Workshop. Workshop Sponsored by French National Agency for Research on AIDS and Viral Hepatitis. May 19, 2015. Assembly Biosciences, Inc. Nasdaq:ASMB) today announced that. PhD, Assembly's Chief Scientific Advisor and Chair of its. HBV and Virology Science Advisory Board. Discussed the science underlying the company's Core Protein Allosteric Modifiers (CpAMs) at the.
TOTAL PAGES IN THIS WEBSITE
20
ABOUT US | ARTEC INC
Investor Events and Presentations. Subscribe to our monthly. Artnec, inc seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming events and presentations and financial documents. Artnec, inc is traded on OTCQX under the ticker symbol ACTL.
Artemis Investor Portal
2018 Artemis Real Estate Partners. This database is not available to the public and is only accessible by our partners and other qualified users.
ARTNEWS S.A.
Abbey House Group S.A. General Meeting of Shareholders. Current and Periodic Reports. ARTNEWS in the Media. The leading source for art coverage since 1902. POLAND’S LEADING MAGAZINE ABOUT ART. WORLD’S OLDEST AND MOST WIDELY CIRCULATED. ART MAGAZINE PUBLISHED IN NEW YORK SINCE 1902. WWWARTNEWS.COM: INTELLIGENCE ON GLOBAL ART TRADE AND COLLECTING. LEADING PROVIDER OF ART INVESTMENT RESEARCH AND ANALYSIS. INTERNATIONAL, UNBIASED, DIGITAL. The leading source for art coverage since 1902. POLAND’S LEADING MAGA...
ASBIS investor portal
More information at WSE website. February 27, 2018. ASBISc Enterprises Plc Published its Consolidated Interim Report for Q4 2017. ASBISc Enterprises Plc, a leading distributor of IT products in emerging markets of Europe, the Middle East and Africa, published its Consolidated Interim Report for Q4 2017. February 27, 2018. ASBIS Results In Q4 2017: Almost 50% Growth In Revenues And Net Profitability Year-On-Year. 357 97 633 793. 357 25 857 288. ASBIS Results in Q4 2017. Current report no 6/2017. Or stop u...
Investor Relations - Ashland Global Holdings Inc.
Board of Director Profiles. Environmental, Health, Safety and Quality Committee Charter. Governance and Nominating Committee Charter. UK Tax Strategies Disclosure. Stock Quote and Chart. Board of Director Profiles. Environmental, Health, Safety and Quality Committee Charter. Governance and Nominating Committee Charter. UK Tax Strategies Disclosure. Stock Quote and Chart. 072 ( 1.042%). 4:02 PM ET on 03/29/2018. Ashland announces price increases for 1-4 butanediol and derivatives in EMEA. Ashland Reports ...
Investor Relations - Assembly Biosciences, Inc.
DAVID J. BARRETT. Russell H. Ellison. William W. Turner. Russell H. Ellison. Assembly Biosciences (Nasdaq: ASMB) is a biopharmaceutical company developing innovative treatments for hepatitis B virus infection (HBV) and C. difficile-associated diarrhea (CDAD). Both programs have breakthrough potential to provide higher cure rates for these debilitating diseases. May 19, 2015. Assembly Biosciences Discusses Mechanism of Action of Its HBV Antiviral Program at 2nd ANRS HBV Cure Workshop. Mar 19, 2015.
Corporate Profile
As of 8/7/2015 -. Minimum 20 minute delay. News and Market Data. As of August 7, 2015 -. Minimum 20 minute delay. Wednesday, August 5, 2015. Associated Banc-Corp Second Quarter 2015 Earnings Call. Thursday, July 16, 2015. Associated Bank becomes Bank of Milwaukee Film Festival. Associated Banc-Corp to Present at Minnesota CFA Conference on August 5, 2015. Associated Bank takes over Chicago's Union Station and encourages riders to 'Challenge Your Bank'. Fannie Mae recognizes Associated Bank as STAR Perfor...
Astir Palace Investor Relations - Board of Directors
List of Corporate Acts. Stock - General index. Group of National Bank of Greece S.A. The composition of the Board of Directors, following the BODs decision dated 2.06.2015. Vice President and Managing Director. Stefanos G. Pantzopoulos. Ιndependent Non- Executive Member. Independent Non- Executive Member. The new B.O.D. term- following the General Meeting s approval dated 10/4/2014- will expire on 30/06/2017. Arion, a Luxury Collection Resort and Spa. W Athens - opening 2011.
Investor Relations - Asure Software
Asset and Move Management. Asset and Move Management. SmartMoveâ eliminates the burden of move management activities by providing floor plan scenarios and tracking data to ensure smooth transitions in your ever-changing business landscape. Office space is always in flux. Impacting your business with move management. December 4, 2015. Hot-desking â The End of The Road? November 22, 2016. Redefining HCM for the forward-thinking workplace. April 18, 2016. April 25, 2016. June 13, 2016. June 15, 2016. Prepar...
404 - PAGE NOT FOUND
ERROR 404 - PAGE NOT FOUND. Why am I seeing this page? 404 means the file is not found. If you have already uploaded the file then the name may be misspelled or it is in a different folder. You may get a 404 error for images because you have Hot Link Protection turned on and the domain is not on the list of authorized domains. It is also possible that you have inadvertently deleted your document root or the your account may need to be recreated. Either way, please contact your web host immediately. When ...
Investor Project Immobilie als Kapitalanlage Wien
SOCIAL ENGAGEMENT